These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Polyglutamic acid-PEG nanocapsules as long circulating carriers for the delivery of docetaxel. Lollo G; Rivera-Rodriguez GR; Bejaud J; Montier T; Passirani C; Benoit JP; García-Fuentes M; Alonso MJ; Torres D Eur J Pharm Biopharm; 2014 May; 87(1):47-54. PubMed ID: 24530693 [TBL] [Abstract][Full Text] [Related]
23. Polyelectrolyte-coated nanocapsules containing undecylenic acid: Synthesis, biocompatibility and neuroprotective properties. Piotrowski M; Jantas D; Szczepanowicz K; Łukasiewicz S; Lasoń W; Warszyński P Colloids Surf B Biointerfaces; 2015 Nov; 135():8-17. PubMed ID: 26231861 [TBL] [Abstract][Full Text] [Related]
24. Anti-Aβ-MAb and dually decorated nanoliposomes: effect of Aβ1-42 peptides on interaction with hCMEC/D3 cells. Markoutsa E; Papadia K; Clemente C; Flores O; Antimisiaris SG Eur J Pharm Biopharm; 2012 May; 81(1):49-56. PubMed ID: 22386910 [TBL] [Abstract][Full Text] [Related]
25. Uptake and transcytosis of functionalized superparamagnetic iron oxide nanoparticles in an in vitro blood brain barrier model. Ivask A; Pilkington EH; Blin T; Käkinen A; Vija H; Visnapuu M; Quinn JF; Whittaker MR; Qiao R; Davis TP; Ke PC; Voelcker NH Biomater Sci; 2018 Jan; 6(2):314-323. PubMed ID: 29239410 [TBL] [Abstract][Full Text] [Related]
26. Inhibition of Leptin-ObR Interaction Does not Prevent Leptin Translocation Across a Human Blood-Brain Barrier Model. Gonzalez-Carter D; Goode AE; Fiammengo R; Dunlop IE; Dexter DT; Porter AE J Neuroendocrinol; 2016 Jun; 28(6):. PubMed ID: 27037668 [TBL] [Abstract][Full Text] [Related]
27. Nanoparticles of alkylglyceryl-dextran-graft-poly(lactic acid) for drug delivery to the brain: Preparation and in vitro investigation. Toman P; Lien CF; Ahmad Z; Dietrich S; Smith JR; An Q; Molnár É; Pilkington GJ; Górecki DC; Tsibouklis J; Barbu E Acta Biomater; 2015 Sep; 23():250-262. PubMed ID: 25983313 [TBL] [Abstract][Full Text] [Related]
28. Receptor-mediated delivery of magnetic nanoparticles across the blood-brain barrier. Qiao R; Jia Q; Hüwel S; Xia R; Liu T; Gao F; Galla HJ; Gao M ACS Nano; 2012 Apr; 6(4):3304-10. PubMed ID: 22443607 [TBL] [Abstract][Full Text] [Related]
29. Memantine transport by a proton-coupled organic cation antiporter in hCMEC/D3 cells, an in vitro human blood-brain barrier model. Higuchi K; Kitamura A; Okura T; Deguchi Y Drug Metab Pharmacokinet; 2015 Apr; 30(2):182-7. PubMed ID: 25857234 [TBL] [Abstract][Full Text] [Related]
30. Cytokine signaling in the human brain capillary endothelial cell line hCMEC/D3. Fasler-Kan E; Suenderhauf C; Barteneva N; Poller B; Gygax D; Huwyler J Brain Res; 2010 Oct; 1354():15-22. PubMed ID: 20692239 [TBL] [Abstract][Full Text] [Related]
31. Quantitative targeted absolute proteomic analysis of transporters, receptors and junction proteins for validation of human cerebral microvascular endothelial cell line hCMEC/D3 as a human blood-brain barrier model. Ohtsuki S; Ikeda C; Uchida Y; Sakamoto Y; Miller F; Glacial F; Decleves X; Scherrmann JM; Couraud PO; Kubo Y; Tachikawa M; Terasaki T Mol Pharm; 2013 Jan; 10(1):289-96. PubMed ID: 23137377 [TBL] [Abstract][Full Text] [Related]
32. A comparative study of chitosan shielding effect on nano-carriers hydrophilicity and biodistribution. Ishak RA; Awad GA; Zaki NM; El-Shamy Ael-H; Mortada ND Carbohydr Polym; 2013 Apr; 94(1):669-76. PubMed ID: 23544589 [TBL] [Abstract][Full Text] [Related]
33. Andrographolide-loaded nanoparticles for brain delivery: Formulation, characterisation and in vitro permeability using hCMEC/D3 cell line. Guccione C; Oufir M; Piazzini V; Eigenmann DE; Jähne EA; Zabela V; Faleschini MT; Bergonzi MC; Smiesko M; Hamburger M; Bilia AR Eur J Pharm Biopharm; 2017 Oct; 119():253-263. PubMed ID: 28652141 [TBL] [Abstract][Full Text] [Related]
34. Clozapine-loaded nanocapsules improve antipsychotic activity in rats: building a sequential PopPK/PD model to discriminate nanocarriers in the preformulation step. Funguetto-Ribeiro AC; Maciel TR; Lunardi AG; Gomes DB; Ibarra M; Haas SE Pharm Res; 2023 Jul; 40(7):1751-1763. PubMed ID: 37349652 [TBL] [Abstract][Full Text] [Related]
35. Development of a PEGylated-Based Platform for Efficient Delivery of Dietary Antioxidants Across the Blood-Brain Barrier. Fernandes C; Pinto M; Martins C; Gomes MJ; Sarmento B; Oliveira PJ; Remião F; Borges F Bioconjug Chem; 2018 May; 29(5):1677-1689. PubMed ID: 29635917 [TBL] [Abstract][Full Text] [Related]
36. Co-culture model consisting of human brain microvascular endothelial and peripheral blood mononuclear cells. Strazza M; Maubert ME; Pirrone V; Wigdahl B; Nonnemacher MR J Neurosci Methods; 2016 Aug; 269():39-45. PubMed ID: 27216631 [TBL] [Abstract][Full Text] [Related]
37. Encapsulation of curcumin in polyelectrolyte nanocapsules and their neuroprotective activity. Szczepanowicz K; Jantas D; Piotrowski M; Staroń J; Leśkiewicz M; Regulska M; Lasoń W; Warszyński P Nanotechnology; 2016 Sep; 27(35):355101. PubMed ID: 27454207 [TBL] [Abstract][Full Text] [Related]